Micropharma (intellectual property assets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Micropharma (intellectual property assets) General Information

Description

Portfolio of intellectual property assets in the probiotic sector. The assets are related to development of the probiotic strain Lactobacillus reuteri NCIMB 30242, which is offered under the mark LRC and the Cardioviva brand of probiotics. It is protected by two families of registered patents.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Montreal
  • Canada
Primary Industry
Buildings and Property
Other Industries
Food Products
Biotechnology
Acquirer
UAS Laboratories
Vertical(s)
Life Sciences
Corporate Office
  • Montreal
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Micropharma (intellectual property assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Micropharma (intellectual property assets)‘s full profile, request access.

Request a free trial

Micropharma (intellectual property assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Micropharma (intellectual property assets)‘s full profile, request access.

Request a free trial

Micropharma (intellectual property assets) FAQs

  • Where is Micropharma (intellectual property assets) headquartered?

    Micropharma (intellectual property assets) is headquartered in Montreal, Canada.

  • What industry is Micropharma (intellectual property assets) in?

    Micropharma (intellectual property assets)’s primary industry is Buildings and Property.

  • Is Micropharma (intellectual property assets) a private or public company?

    Micropharma (intellectual property assets) is a Private company.

  • What is Micropharma (intellectual property assets)’s current revenue?

    The current revenue for Micropharma (intellectual property assets) is .

  • Who are Micropharma (intellectual property assets)’s investors?

    Micropharma has invested in Micropharma (intellectual property assets).

  • When was Micropharma (intellectual property assets) acquired?

    Micropharma (intellectual property assets) was acquired on 02-Dec-2014.

  • Who acquired Micropharma (intellectual property assets)?

    Micropharma (intellectual property assets) was acquired by UAS Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »